跳至主要内容
临床试验/JPRN-UMIN000035263
JPRN-UMIN000035263已完成4 期

Study for the effect of SGLT2 inhibitors in high risk patients of dialysis with type 2 diabetes - The effect of SGLT2 inhibitors in patients with renal dysfunction

Kurihara Naika Clinic0 个研究点目标入组 75 人开始时间: 2018年12月15日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
75

研究概览

简要总结

%DeGFR+2y in patients who were treated with SGLT2i was significantly increased compared with the patients not treated with SGLT2i (2.3 and -21.7%, respectively; P < 0.0001). There was no increase in serious adverse events including acute kidney injury. SGLT2i was safe, and prevented further eGFR decline in patients with type 2 diabetes and advanced renal dysfunction.

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)type 1 diabetes 2)severe liver dysfunction 3)pregnancy, nursing woman or possibly pregnant woman 4)severe diabetic ketosis, diabetic coma 5)severe infection, pre and post operation , severe trauma 7) uncontrolled diet therapy 8) poor adherence for medication 9) patients who thought to be inappropriate to enter this study for some reasons by physician's judgments

研究者

发起方
Kurihara Naika Clinic

相似试验